- Home
- PSTV vs EDSA Comparison
PSTV vs EDSA Comparison
Compare PSTV & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTV
- EDSA
- Stock Information
- Founded
- PSTV 1996
- EDSA 2015
- Country
- PSTV United States
- EDSA Canada
- Employees
- PSTV N/A
- EDSA N/A
- Industry
- PSTV Medical/Dental Instruments
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- PSTV Health Care
- EDSA Health Care
- Exchange
- PSTV Nasdaq
- EDSA Nasdaq
- Market Cap
- PSTV 7.9M
- EDSA 7.1M
- IPO Year
- PSTV N/A
- EDSA N/A
- Fundamental
- Price
- PSTV $1.18
- EDSA $2.11
- Analyst Decision
- PSTV Strong Buy
- EDSA Strong Buy
- Analyst Count
- PSTV 2
- EDSA 1
- Target Price
- PSTV $14.00
- EDSA $21.00
- AVG Volume (30 Days)
- PSTV 111.7K
- EDSA 49.6K
- Earning Date
- PSTV 11-14-2024
- EDSA 12-13-2024
- Dividend Yield
- PSTV N/A
- EDSA N/A
- EPS Growth
- PSTV N/A
- EDSA N/A
- EPS
- PSTV N/A
- EDSA N/A
- Revenue
- PSTV $5,725,000.00
- EDSA N/A
- Revenue This Year
- PSTV $11.13
- EDSA N/A
- Revenue Next Year
- PSTV N/A
- EDSA N/A
- P/E Ratio
- PSTV N/A
- EDSA N/A
- Revenue Growth
- PSTV 52.63
- EDSA N/A
- 52 Week Low
- PSTV $1.15
- EDSA $2.05
- 52 Week High
- PSTV $2.67
- EDSA $6.46
- Technical
- Relative Strength Index (RSI)
- PSTV 40.01
- EDSA 23.05
- Support Level
- PSTV $1.16
- EDSA $2.09
- Resistance Level
- PSTV $1.42
- EDSA $2.32
- Average True Range (ATR)
- PSTV 0.11
- EDSA 0.23
- MACD
- PSTV -0.01
- EDSA 0.00
- Stochastic Oscillator
- PSTV 6.06
- EDSA 6.52
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.